Autonomous Agentic AI Systems for Pharmaceutical Drug Discovery: A Multi-Agent Framework for Molecular Design and Optimization

Contemporary drug discovery represents an extraordinarily complex and capital-intensive scientific challenge, characterized by development timelines extending 10-15 years and clinical failure rates surpassing 90%. Existing computational frameworks operate within fragmented ecosystems that demand persistent human oversight and require laborious coordination across heterogeneous analytical workflows. This research introduces a autonomous agentic artificial intelligence platform engineered to transform pharmaceutical research through intelligent multi-agent orchestration. The developed architecture coordinates specialized computational agents that function synergistically across molecular design, property prediction , synthetic pathway optimization, and multi-criteria decision-making processes. Through integration of advanced transformer-based molecular representation learning, multi-agent reinforcement learning paradigms, and privacy-preserving federated learning infrastructures, the system enables autonomous model collaboration while maintaining strict data sovereignty. This research provides foundational theoretical frameworks, defines modular architectural specifications, and validates implementation protocols for next-generation autonomous drug discovery platforms. The framework addresses critical limitations in current methodologies through autonomous reasoning capabilities, adaptive exploration strategies, and coordinated optimization across conflicting research priorities. The resulting platform represents a significant leap toward fully autonomous pharmaceutical discovery pipelines, demonstrating potential for dramatic timeline compression while enhancing therapeutic development success rates.